RxDoctor Payments Data

Katherine Ma, MD

Foot and Ankle Surgery · Cortlandt Manor, NYNPI 1992063382

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $36,453 of the $54,446 with a category attached, or 67.0%. Arthrex accounts for 79.9% of it on its own, with 8 other manufacturers making up the rest. Among foot and ankle surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,446in general payments, 2019–2025

Across 139 payments — averaging $391.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$44K
  • Gotham Surgical Solutions & Devices, Inc.$7K
  • Stryker$2K
  • Treace Medical Concepts, Inc.$1K
  • Smith+Nephew$579
  • Bioventus LLC$150
  • plus $314 from 3 others

What the payments were for

  • Consulting fees$7501%
  • Speaking & faculty fees$36,45367%
  • Travel & lodging$6,77812%
  • Food & beverage$3,8377%
  • Education$6,53412%
  • Gifts$940%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,446 in reported general payments places this provider in the 95th percentile of 652 foot and ankle surgery providers in New York.

See all foot and ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$168,455
Medicare patients
406
Services billed
4,805

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium41$768
Meloxicam80$381
Ketorolac Tromethamine13$201

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Cortlandt Manor

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →